Floatz logo

Dantrolene

Ataxia

Washington University School of MedicineSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Ataxia cohort.

Asset / SponsorPhaseRating
PBR-06
Brigham and Women's Hospital
D

Same molecule, other indications

Dantrolene is also rated in:

Wolfram syndromeDormant
CCC
Indicative ·
52 / 100
View asset →
optic atrophyDormant
CCC
Indicative ·
52 / 100
View asset →
diabetes mellitusDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →